Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting

NCT02546232 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

196

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Oslo University Hospital